Point72 Asset Management
LUMO

Point72 Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Point72 Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,853
Closed -$1.82M – 1125
2017
Q3 		$1.82M Buy
+19,853
New +$1.52M 0.01% 690
2017
Q2 		– Sell
-4,444
Closed -$964K – 1037
2017
Q1 		$964K Buy
+4,444
New +$635K 0.01% 739

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's LUMO Position: Q4 2017 in Review

Point72 Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2017, closing a stake of 19,853 shares — an estimated $1.82M sold.

Point72 Asset Management first reported a position in LUMO in Q1 2017 and held it in 2 quarters. The position peaked at $1.82M in Q3 2017. 130 funds tracked by Wall St. Rank hold LUMO as of Q4 2017.

  • Point72 Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Point72 Asset Management sold 19,853 Lumos Pharma, Inc. Common Stock shares in Q4 2017, an estimated $1.82M.
  • Point72 Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Point72 Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $1.82M in Q3 2017.
  • 130 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2017.

Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.